Boston Scientific completes acquisition of Vertiflex

Boston Scientific Corporation has completed the acquisition of Vertiflex, Inc., a privately held company that developed and commercialized the Superion Indirect Decompression System. The acquisition of Vertiflex adds the only FDA-approved, commercially-available, minimally invasive interspinous spacer to the industry-leading pain management portfolio from Boston Scientific, which also includes spinal cord stimulation and radiofrequency ablation. As noted in the definitive agreement announcement, the transaction consists of USD 465 million in upfront cash and additional payments contingent on commercial milestones for the next 3 years.

Share this:

Related Post

Stay Updated on Medical Equipment and Devices industry.
Receive our Daily Newsletter.